Britannia Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 19, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	15	12	11	15	31	-
Market Cap Growth	46.15%	7.14%	-26.32%	-49.89%	-	-
Enterprise Value	-0	23	21	25	38	-
Last Close Price	0.10	0.07	0.07	0.10	0.19	-
PE Ratio	1.94	1.65	-	3.03	-	-
PS Ratio	97.76	32.95	21.98	2.41	4.21	-
PB Ratio	0.89	1.93	1.70	1.39	5.61	-
P/TBV Ratio	0.89	1.93	-	-	-	-
P/FCF Ratio	-	-	5.43	7.89	11.34	-
P/OCF Ratio	-	-	5.43	7.68	10.99	-
EV/Sales Ratio	-	62.12	40.45	3.90	5.26	-
EV/EBITDA Ratio	-	-	-	22.64	21.88	-
EV/EBIT Ratio	-	-	-	25.15	23.75	-
EV/FCF Ratio	-	-	9.99	12.80	14.15	-
Debt / Equity Ratio	0.01	0.30	1.09	0.76	0.95	3.96
Debt / EBITDA Ratio	-	-	-	7.31	2.88	32.63
Debt / FCF Ratio	-	-	3.48	4.31	1.92	-
Net Debt / Equity Ratio	-0.91	-0.95	0.89	0.53	0.65	3.65
Net Debt / EBITDA Ratio	6.54	2.83	-4.19	5.26	2.03	30.67
Net Debt / FCF Ratio	3.77	2.29	2.85	2.98	1.31	-17.88
Asset Turnover	0.01	0.02	0.02	0.29	0.34	0.13
Quick Ratio	3.44	2.21	0.24	0.91	0.41	0.25
Current Ratio	3.55	2.72	0.26	0.92	0.42	0.25
Return on Equity (ROE)	67.82%	-70.32%	-68.98%	70.57%	-343.40%	10.72%
Return on Assets (ROA)	-7.05%	-8.18%	-4.23%	2.78%	4.75%	1.67%
Return on Invested Capital (ROIC)	-49.99%	-34.23%	-10.50%	7.65%	15.08%	0.90%
Return on Capital Employed (ROCE)	-14.40%	-27.80%	-13.20%	5.20%	12.70%	2.60%
Earnings Yield	132.92%	60.75%	-41.98%	32.98%	-50.26%	-
FCF Yield	-	-21.53%	18.42%	12.67%	8.82%	-
Buyback Yield / Dilution	-	-	-0.07%	-48.07%	-41.06%	-1138.06%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.